Treatment and Clinical Management of Chronic Thromboembolic Pulmonary Hypertension: An Update of Literature Review

被引：2

作者：

Ren, Yuan ^{[1
]}

Sun, Yingxian ^{[1
]}

Yang, Zhiguang ^{[2
]}

Chen, Yanli ^{[1
]}

机构：

[1] China Med Univ, Affiliated Hosp 1, Dept Cardiol, Shenyang 110000, Peoples R China

[2] China Med Univ, Shengjing Hosp, Radiol Dept, Shenyang 110020, Peoples R China

来源：

CONGENITAL HEART DISEASE | 2024年 / 19卷 / 02期

关键词：

Chronic thromboembolic pulmonary hypertension (CTEPH); chronic thromboembolic pulmonary disease (CTEPD); pulmonary endarterectomy (PEA); balloon pulmonary angioplasty (BPA); COVID-19; RISK-FACTORS; ENDARTERECTOMY; ANGIOPLASTY; EXERCISE; EMBOLISM; DISEASE; THROMBOENDARTERECTOMY; MULTICENTER; SILDENAFIL; EXPERIENCE;

D O I：

10.32604/chd.2024.047930

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic, progressive, debilitating, and life -threatening complication of pulmonary embolism (PE). Recent technological advances have permitted various treatment options for the treatment of CTEPH, including surgery, angioplasty, and medical treatment, depending on the location and characteristics of lesions. Pulmonary endarterectomy (PEA) is the treatment of choice for CTEPH, as it offers excellent long-term outcomes and a high probability of recovery. Moreover, various medical and interventional therapies are currently being developed for patients with inoperable CTEPH. This review mainly summarizes the current treatment approaches of CTEPH, offering more options for specialist physicians to, thus, better manage chronic thromboembolic syndromes.

引用

页码：157 / 176

页数：20

共 50 条

[21] Chronic thromboembolic pulmonary hypertension
Hoeper, Marius M.
Madani, Michael M.
Nakanishi, Norifumi
Meyer, Bernhard
Cebotari, Serghei
Rubin, Lewis J.
[J]. LANCET RESPIRATORY MEDICINE, 2014, 2 (07) : 573 - 582
[22] Chronic Thromboembolic Pulmonary Hypertension
Buck, Emory
Kearns, Sean
Dahhan, Talal
Parikh, Kishan S.
Krasuski, Richard A.
Rajagopal, Sudarshan
[J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2024, 20 (03) : 188 - 201
[23] Chronic thromboembolic pulmonary hypertension
Kim, Nick H.
Delcroix, Marion
Jais, Xavier
Madani, Michael M.
Matsubara, Hiromi
Mayer, Eckhard
Ogo, Takeshi
Tapson, Victor F.
Ghofrani, Hossein-Ardeschir
Jenkins, David P.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
[24] Pulmonary Hypertension 3 Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management
Delcroix, Marion
de Perrot, Marc
Jais, Xavier
Jenkins, David P.
Lang, Irene M.
Matsubara, Hiromi
Meijboom, Lilian J.
Quarck, Rozenn
Simonneau, Gerald
Wiedenroth, Christoph B.
Kim, Nick H.
[J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (09) : 836 - 850
[25] Chronic Thromboembolic Pulmonary Hypertension
Moraca, Robert J.
Kanwar, Manreet
[J]. HEART FAILURE CLINICS, 2012, 8 (03) : 475 - +
[26] Chronic thromboembolic pulmonary hypertension
Gabriel Botella, Francisco
Labios Gomez, Manuel
Corella Piquer, Dolores
[J]. MEDICINA CLINICA, 2012, 139 (05): : 215 - 220
[27] Surgical Management of Chronic Thromboembolic Pulmonary Hypertension
Vekstein, Andrew M.
Nellis, Joseph R.
McCartney, Sharon L.
Haney, John C.
[J]. CARDIOLOGY CLINICS, 2022, 40 (01) : 89 - 101
[28] Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment
Kim, Nick H.
[J]. CARDIOLOGY CLINICS, 2016, 34 (03) : 435 - +
[29] Advances in treatment of chronic thromboembolic pulmonary hypertension
Tzoumas, Andreas
Peppas, Spyridon
Sagris, Marios
Papanastasiou, Christos A.
Barakakis, Paraschos Archontakis
Bakoyiannis, Christos
Taleb, Adam
Kokkinidis, Damianos G.
Giannakoulas, George
[J]. THROMBOSIS RESEARCH, 2022, 212 : 30 - 37
[30] Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension
Otani, Naoyuki
Watanabe, Ryo
Tomoe, Takashi
Toyoda, Shigeru
Yasu, Takanori
Nakamoto, Takaaki
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)

← 1 2 3 4 5 →